ATECTURA BREEZHALER 125 micrograms/127.5 micrograms, powder for inhalation in capsules capsule, CIP 3400930207772
Active ingredients: Indacaterol acetate, Mometasone furoate, Indacaterol
Commercialized according to BDPMDispensing in France: Prescription only
Powder for inhalation in capsulescapsule, CIP 3400930207772inhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ATECTURA BREEZHALER 125 microgrammes/127,5 microgrammes, poudre pour inhalation en gélule
- Pharmaceutical form
- poudre pour inhalation en gélule
- Route of administration
- inhalée
- Presentation description
- plaquette(s) unidose(s) polyamide aluminium PVC-Aluminium de 30 x 1 gélule (en dose unitaire) + 1 inhalateur
- Marketing authorisation holder
- NOVARTIS EUROPHARM (IRLANDE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 May 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64670426CIP73020777CIP133400930207772Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FUROATE DE MOMÉTASONEpoudre | 160 microgrammes · une gélule | SA |
| ACÉTATE D'INDACATÉROLpoudre | — | SA |
| INDACATÉROLpoudre | 150 microgrammes · une gélule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.